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Background & aims: To investigate the effects of glucose, parenteral amino acids, and intravenous insulin
on albumin synthesis rates in critically ill children.
Methods: Two studies were performed in 8 post-surgical infants (age 9.8  1.9 months; weight
9.5  1.1 kg) and 9 septic adolescents (age 15  1 yr; BMI 23  4 kg m2), respectively. All received
a primed, constant, tracer infusion with [1-13C]Leucine. The infants in study 1 were randomized to
receive low (2.5 mg kg1 min1) and standard (5.0 mg kg1 min1) glucose intake in a cross-over setting
of two periods of 4 h each. The adolescents in study 2 were randomized to receive total parenteral
nutrition with standard (1.5 g kg1 day1) and high (3.0 g kg1 day1) amino acid intake in a two day
cross-over setting. On both study days, during the last 3 h of the tracer study, they received insulin
infused at 80 mU m2 min1.
Results: The post-surgical infants and the septic adolescents were mildly hypoalbuminemic (w2.5 g dL1)
with high synthesis rates, which were not affected by different intakes of glucose, amino acids, or insulin
infusion.
Conclusions: Albumin synthesis rates in hypoalbuminemic critically ill children are high but were not
upregulated through nutrient supply, and in septic adolescents are unaffected by insulin.
 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism.
Open access under the Elsevier OA license.1. Introduction
Albumin is the most abundant protein in human plasma with
a normal plasma concentration of around 4.0 g dL1, while about
60% of the total albumin pool is located in the interstitial space.1
Albumin holds several important functions, both in health as well
as in critically ill patients. It is the main preserver of colloid oncotic
pressure (w75%), it functions as an anticoagulant and anti-oxidant
and it is an important binding transporter of metabolites and
drugs.1,2; LG, low glucose intake; SG,
ntake; HAA, high amino acid
rcent excess; KIC, a-ketoiso-
rance.
l Center, De Boelelaan 1117,
.
Verbruggen).
for Clinical Nutrition and MetabolCritically ill patients are often hypoalbuminemic, primarily due
to dilution and redistribution secondary to an altered vascular
permeability.1 In critically ill patients hypoalbuminemia has been
documented as a marker for disease severity, nutritional status,
prolonged ventilator support and prolonged length of stay.3,4 In
critically ill adults and children, low albumin plasma levels
(<3.3 g dL1) are inversely related to morbidity and mortality,
where in adults each 1.0 g dL1 drop in serum albumin raised the
odds of morbidity by 87% and mortality by 137%.3e5 However,
plasma concentrations are static measurements. Dynamic
measurements by means of albumin synthesis rates actually show
a consistent increase in critically ill adults.6,7
Despite the clear association between hypoalbuminemia and
poor outcome, there is still a debate on the beneﬁts and safety of
intravenous albumin administration, partially due to the increased
risk of escape in the extravascular space and inﬂammation.2,5
Therefore, stimulation of endogenous albumin synthesis seems
an appealing alternative.ism.Open access under the Elsevier OA license.
Fig. 1. Experimental design of study 1 in 8post-surgical infants admitted to thepediatric
intensive careunit receivingonlyparenteral glucose asnutrition, LG¼ lowglucose intake
(2.5 mg kg1 min1), SG ¼ standard glucose (5.0 mg kg1 min1), Eleuc-alb
¼ Enrichment of [1-13C]Leucine incorporated into albumin, VCO2 ¼ Carbon dioxide
production.
S.C. Verbruggen et al. / Clinical Nutrition 30 (2011) 469e477470Albumin synthesis can be stimulated by an increase in energy
(glucose and fat) but is particularly responsive to amino acid
intake.8e10 Hyperinsulinemia has shown to increase albumin
synthesis as well, with an additive effect of increased amino acids in
healthy adults.10 This latter intervention is of particular interest as
insulin is more frequently used to treat hyperglycemia in critically
ill adults and children.11 Moreover, the increase in synthesis rates in
response to these interventions is immediate and fast. Albumin
synthesis rates increased by 40% within 2 h following intravenous
endotoxin in healthy volunteers.12 Furthermore, nutritional
supplementation13,14 and hyperinsulinemia15 increased albumin
synthesis rates, within 4, 6, and 3 h respectively.
The effect of various nutritional interventions on albumin
synthesis rates have not been investigated in critically ill children,
other than in premature infants.16 Increasing amino acid availability
resulted in higher albumin synthesis rates, although not as high as
reached in utero.16 Given the limited knowledge of albumin
synthesis rates and the impact of nutrition in the critically ill
pediatric population, we set out to ascertain these.We hypothesized
that in critically ill children albumin synthesis rates are increased
and responsive to nutrients and hyperinsulinemia. Therefore, our
ﬁrst objective was to quantify albumin synthesis rates in critically ill
infants and adolescents. Our second objective was to determine theFig. 2. Experimental design of study 2 in 9 adolescents admitted to the pediatric intensive
baseline and during hyperinsulinemia, Panel A Two day study protocol with two different am
both days during baseline and during hyperinsulinemia, SAA ¼ Standard amino acid int
¼ Enrichment of [1-13C]Leucine incorporated into albumin, VCO2 ¼ Carbon dioxide producimpact of nutrients on albumin synthesis rates in these children,
with special emphasis on parenteral glucose and amino acids. Our
third objective was to determine whether additional hyper-
insulinemia in combinationwith parenteral glucose and amino acid
intakewould increase albumin synthesis rates through a synergistic
fashion. The here described studies were part of two larger studies
aiming to investigate the effect of reduced glucose intake on glucose
homeostasis and protein catabolism (Study 1) and the effect and
interactions of increased amino acid intake and hyperinsulinemia
on substrate metabolism and insulin resistance (Study 2).
2. Methods
2.1. Patients
Study 1 was a one day study with infants (0.5e1.0 y) admitted
after surgical repair of non-syndromal craniosynostosis to the
pediatric intensive care unit (PICU) at Erasmus MC e Sophia Chil-
dren’s Hospital in Rotterdam, The Netherlands. Study 2 was a two
day study in adolescents (13e18 y) who were admitted with
a diagnosis of severe sepsis or Systemic Inﬂammatory Response
Syndrome (SIRS), as deﬁned by the criteria of the First International
Pediatric Sepsis Forum17 to the PICU at Texas Children’s Hospital,
Houston, Texas. All patients had drawing and infusing catheters in
place for clinical purposes. Patients with metabolic diseases, dia-
betes mellitus, primary liver, or renal failure were excluded. The
study protocols were approved, respectively by the Institutional
Review Board of Erasmus Medical Center, Rotterdam, The
Netherlands and by the Institutional Review Board of Baylor College
of Medicine, Houston, Texas. Studies were carried out after written
informed consent from the parents.
2.2. Study design and data collection
The experimental design of study 1 is shown in Fig. 1 and con-
sisted of an 8 h glucose infusion in a randomized, cross-over design,care unit receiving full parenteral nutrition with two different amino acid intakes at
ino acid intakes in a randomized cross-over fashion, Panel B Isotope tracer infusion on
ake (1.5 g kg1 day1), HAA ¼ High amino acid intake (3.0 g kg1 day1), Eleuc-alb
tion.
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5.0 mg kg1 min1) glucose intake rates. Patients were randomized
for the order of glucose intake through a computer generated
envelop. Laboratory personnel, the clinical team and investigators
were blinded for glucose intake until after analyses were ﬁnished.
Prior to the study, infants did not receive (par)enteral nutrition
other than intravenous glucose infusion in the range of
4e6 mg kg1 min1 as per standard care before start of the study.
Eight hours after admission to the PICU and after obtaining baseline
blood samples, the intravenous glucose intake as per standard care
(4.0e6.0 mg kg1 min1) was stopped and the study glucose intake
started (t ¼ 0), after which the patients received a primed,
continuous, 8 h intravenous tracer infusionwith L-[1-13C]leucine at
8 mmol kg1 and 8 mmol kg1 h1 respectively. Four hours after start
of the study (t ¼ 240) the study glucose was switched as per cross-
over design (Fig. 1).
Study 2 consisted of 2 study days in a randomized cross-over
fashion, i.e. one with standard (SAA; 1.5 g kg1.day1) and one with
high (HAA; 3.0 g kg1.day1) amino acid intake via total parenteral
nutrition (TPN) (Fig. 2a). Patients received full parenteral nutrition
(Aminosyn (Hospira Inc. Lake Forest, IL.) or Clinisol (Baxter, Deerﬁeld,
IL)) for at least 24 h before the start of the study. Both days consisted
of two experimental periods, a basal and a period with insulin
infusion (see subsequent description at the end of the paragraph)
(Fig. 2b). Amino acid intake was randomized by pharmacy through
a computer generated envelop. Insulin infusion always followed
a baseline period because of the expected wash-out effect of insulin
on protein metabolism. Laboratory personnel was blinded for both
the amino acid intake and the insulin allocation, while investigators
were blinded for amino acid intake, but could not be blinded for
insulin allocation due to the risk of hypoglycemia. Energy intake
provided as parenteral glucose and lipids were prescribed by the
clinical team according to standard care. The total energy intake
supplied remained unchanged during both study days. After an
adaptation period of at least 12 h of the randomized TPN, the patients
received a primed, continuous, 7 h infusion with L-[1-13C]leucine at
6 mmol kg1 and 6 mmol kg1 h1 respectively, ofwhich the last 3 h in
combination with a hyperinsulinemic euglycemic clamp as previ-
ously described18 (Fig. 2b). Brieﬂy, a 3 h infusion of insulin (Actrapid,
Novo Nordisk Inc., Princeton, NJ), dissolved in sterile isotonic NaCl
was started at 80 mU m2 min1 in order to achieve both normo-
glycemia between 90 and 110 mg dL1 and a plasma insulin
concentration greater than 100 mU mL1. During insulin infusion,
small blood samples were obtained from the indwelling arterial
catheter every 5e10 min to monitor whole blood glucose concen-
tration, at the bedside with the aid of a Y.S.I. 2300 STAT Plus analyzer
(YSI Life Sciences, Yellow Springs, OH). To maintain the plasma
glucose between 90 and 110 mg dL1 (5.0e6.1 mM) for the duration
of the study, a 30% glucose solution was infused with a Harvard
syringe pump (PHD 22/2000, Harvard apparatus, Holliston, MA).18
3. Materials
L-[1-13C]leucine (99 atom%) was purchased from Cambridge
Isotope Laboratories (Andover, MA) and tested for sterility and
pyrogenicity after they were compounded at the investigational
pharmacy at Texas Children’s Hospital or Erasmus MC e Sophia
Children’s Hospital.
3.1. Measurements and sample analysis
Basal metabolic rate was predicted using the Schoﬁeld equa-
tion.19 All were assessed for severity of disease by the Pediatric
Logistic Organ Dysfunction (PELOD) score20 and the Pediatric Risk
of Mortality III (PRISM III) score.21Blood samples were obtained from the arterial line at standard
frequent intervals (Fig. 1) and immediately centrifuged and frozen
at 80 C until samples were analyzed. To isolate albumin from
plasma, we used anti-human serum albumin afﬁnity resin kits
(Vivascience; Sartorius Group, Hannover, Germany). Enclosed spin
columns were ﬁlled with 400 mL afﬁnity resin and 25 mL of thawed
plasma. The column was washed 3 times with a tris-buffer, and
albumin was thereafter eluted from the afﬁnity resin with 0.1 mol
glycine/L (acidiﬁed to pH 2.5 with HCl). Eluted albumin was
precipitated with 750 mL of 2 mol HClO4/L. A washing step was
performed with 0.2 mol HClO4/L by resuspending and precipitating
the pellet again. The protein pellet was then hydrolyzed in 140 mL of
6 mol HCl/L for 22 h at 110 C. After hydrolyzation, the acid was
evaporated by using a speedvac, after which the dried amino acids
were dissolved in H2O. Samples were derivatized using propyl-
chloroformate (commercial kits: Phenomenex for hydrolyzates,
EZ:Faast, Bester BV, Amstelveen, the Netherlands) and measured in
triplicate on a gas chromatographecombustioneisotope ratio mass
spectrometer (GC-C-IRMS; Delta XP, Thermo Electron, Bremen,
Germany).22 As albumin precursor, we used plasma [1-13C]a-ketoi-
socaproate (a-KIC; the keto-acid of leucine, a measure of intracel-
lular leucine enrichment) enrichment at a plateau. Liver amino
acyl-tRNA enrichment forms the true precursor, but its use requires
tissue biopsies and technically demanding assays. Nevertheless,
a-KIC enrichment adequately represents leucyl-tRNA enrichment
and is valuable in this type of research.23,24 Plasma isotope enrich-
ment of [1-13C]a-KIC were, after derivatization to butyldimethyl-
silylquinoxalinol derivatives, determined by gas chromatography
mass spectrometry (GCeMS) as previously described.25 Plasma
albumin concentrations were routinely measured on a Hitachi 912
autoanalyzer (Roche Diagnostics, Basel, Switzerland).
Carbon dioxide production (VCO2) was obtained with a respira-
tory proﬁle monitor (DeltatracTM I MBM-200, Datex Division
Instrumentarium Corp. Finland/CO2SMO Plus, Novametrix Medical
System, Wallingford, CT, USA) during the last 30 min of each study
period. To determine the enrichment of 13CO2 (E13CO2) in whole
blood, 1 mL of perchloric acid 10% was added to 1.0 mL of whole
blood in a vacutainer to release the CO2. The 13CO2 in gas was
subsequently determined on gas combustion isotope ratio mass
spectrometry (GC-IRMS).26,27
Plasma glucose levels >110 mg dL1 (w>6.1 mmol L1) were
considered hyperglycemic and plasma albumin levels <3.5 g dL1
were considered hypoalbuminemic.
3.2. Calculations
Whole body kinetics of leucine were calculated by conventional
isotope dilution technique using a stochastic model during steady
state plateau.28 The rate of appearance (Ra) of unlabeled leucine
can be derived from the plasma isotope enrichment calculated by:
Raleu ¼ i x
 
Einf=Epl  1
!
(1)
where i is the infusion rate of [1-13C]Leucine, Einf is the tracer
enrichment of the infusate and Epl the tracer enrichment in plasma,
respectively. At steady state plateau rate of appearance (Ra) is equal
to rate of disappearance (Rd).
The fractional albumin synthesis rate (FSR) reﬂects the fraction
of the intravascular albumin pool that is renewed per unit of time
(%.d1) and can be calculated by using the following equation16:
FSR ¼ Eleualb;t2  Eleualb;t1=Eakic  ð24 60Þ=ðt2 t1Þ
 100%
(2)
Table 1
Patient demographics of 8 infants and 9 adolescents admitted to the PICUa
Study 1 Study 2
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incorporated leucine in albumin at t1 and t2 (Figs. 1 and 2), and Ea-
kic is the mean enrichment in MPE of the precursor, ie, plasma a-
KIC, at these time points in minutes.
The absolute albumin synthesis rate (ASR) represents the abso-
lute amount of albumin that is produced per day (mg kg1 d1), and
it can be calculated by using the following equation16:
ASR ¼ FSR  Calb  volbl  ð1 HtÞ weight1 (3)
where Calb is the plasma albumin concentration in gL1, volbl is the
child’s total blood volume in mL (assumed to be 75 and 70 mL/kg
body wt for the infants and adolescents respectively), Ht stands for
hematocrit and (1eHt) is the fraction of blood that is plasma.
We also calculated the contribution (%) of albumin ASR in
relation to whole body protein synthesis in percentage on the basis
of measured leucine turnover data. To do so we needed to deter-
mine leucine oxidation and the non-oxidative leucine disposal
(NOLD) representing leucine utilized into whole body protein
synthesis (in mmol kg1 h1).
Leucine oxidation rates were calculated as follows;
Leucine Oxidation ¼ VCO2 
 
E13CO2=69:18
!
=½13Ca KIC
(4)
where 69.18 is the 13CO2 refraction correction factor for critically ill
children.29 VCO2 is measured in milliliters per minute and con-
verted to millimoles per hour by multiplying by 60 min and
dividing by 22.4, which is the number of 1 in 1mol of an ideal gas at
standard temperature and pressure to convert to milliliters per
minute.
NOLD is the leucine oxidation subtracted from the leucine rate
of disappearance;
NOLD ¼ Raleu  Leucine Oxidation (5)
This allows us to calculate the contribution of albumin synthesis
in ratio to the whole body protein synthesis according to the
following equation16:
Contribution ¼

ðASR  0:104Þ=ðNOLD 131:2 24 0:001Þ

 100%
(6)
where 0.104 represents the fraction of leucine residues in albumin
on a weight basis, 131.2 is the mole mass of leucine, and 24 and
0.001 convert to day and milligram, respectively.Age (years) 0.8  0.2 15.0  1.2
Gender (male:female) 6:2 3:6
Tanner-score 4.0  0.8
Body mass index (kg m2) 20  4
Weight (kg) 9.5  1.1 49.1  13.1
Length (cm) 74.3  3.0 154.3  11.6
SAAb HAAc
PICU LOSd (days) 1 5.9  3.3 6.3  3.6
C-Reactive protein (mg dL1) 2.4  1.3 16.5  9.4 15.1  12.0
PELODe 10  9 9  11 6  7
PRISM IIIf 7  4 10  4 8  4
Catecholamines (n) 0 1 0
Glucocorticoids (n) 0 4 3
a All values are mean  SD.
b SAA ¼ standard amino acid intake (1.5 g kg1 d1).
c HAA ¼ high amino acid intake (3.0 g kg1 d1).
d PICU LOS ¼ Length of stay in the PICU at start of the study.
e PELOD ¼ Pediatric Logistic Organ Dysfunction.20
f PRISM III ¼ Pediatric Risk of Mortality III.213.3. Statistical analysis
A prospective power analysis on our previous data on albumin
synthesis rates16 revealed that 8 patients with complete data,
would detect a difference of 20% (80% power, type I error of 5%) in
synthesis rates. Data are presented as the mean  standard devi-
ation unless non-parametric in which case they are presented as
median and 95% CI. Due to the variation between the two studies,
not only in nutritional and metabolic support, but moreover in age
and diagnosis, statistical comparison would not be justiﬁed.
Differences within study groups were tested by use of the Bonfer-
roni multiple comparison for selected pairs after repeated
measurements ANOVA, after which a paired student’s t test was
used. For non-parametric data the Wilcoxon matched pairs or
Mann Whitney was used. Statistical signiﬁcance was considered atp < .05. Data were analyzed with Graphpad Prism 5.0.3 (Graphpad
Software, La Jolla, CA., USA).
4. Results
4.1. Patients
The demographic characteristics of all patients are described in
Table 1.
4.1.1. Study 1
Study 1 included 8 post-surgical infants (age 0.8  0.2 months;
9.5  1.1 kg). All patients were hemodynamically stable without
vasoactive drugs and all patients were breathing spontaneous with
an inspiratory fraction of oxygen less than 0.6.
4.1.2. Study 2
Study 2 included nine septic adolescents (age 15  1 yr; BMI
20  4 kg m2, Tanner-score 4.0  0.8). All patients were
mechanically ventilated and hemodynamically stable. One patient
received epinephrine as vasopressor therapy and 4 patients
received glucocorticoids as additional therapy (Table 1). One
patient randomized to start ﬁrst with the standard amino acid
intake group (SAA) died the next day after the ﬁrst study (SAA) was
completed, therefore the high amino acid intake (HAA) part of the
study could not be conducted. In a second patient a technical error
occurred during the insulin infusion protocol on the study day with
SAA intake. Therefore, complete two day study data were available
on 7 patients. Data available from the two incomplete studies were
included according to intention-to-treat principle.
4.2. Nutritional interventions
The nutritional characteristics of all patients are described in
Table 2.
4.2.1. Study 1
The infants received glucose intake in two different amounts
and did not receive any amino acids. As anticipated, the caloric
intake was below the caloric requirements according to the Scho-
ﬁeld equations,19 although signiﬁcantly higher during SG. During
LG the infants were normoglycemic, and during SG glucose levels
were higher and hyperglycemic, while the insulin plasma levels did
not signiﬁcantly differ.
Table 2
Nutritional parameters of 8 infants and 9 adolescents admitted to PICUa
Study 1 Study 2
LGb SGc SAAd HAAe
Base Insulin Base Insulin
Schoﬁeldf (kcal.kg1 day1) 53.7  5.3 29.3  6.0 29.3  6.0
Caloric intake (kcal kg1 day1) 12.7  0.2 25.3  0.5g 32.7  10.0 41.8  8.4 37.8  9.9 43.0  14.3
Caloric intake (% of Schoﬁeld) 24  1 47  2g 115  39 147  44 136  31 156  55
Glucose intake (mg kg1 min1) 2.6  0.1 5.2  0.1g 4.5  1.7 6.2  1.9 4.6  1.5 5.6  2.2
Protein intake (g kg1 day1) 0 0 1.5  0.2 1.5  0.2 2.8  0.4i 2.8  0.4i
Glucose calories (kcal kg1.day1) 12.7  0.2 25.3  0.5g 21.8  8.1 30.9  8.9 22.4  7.6 27.6  10.8
Amino acid calories (kcal kg1 day1) 0 0 5.8  0.8 5.8  0.8 11.2  1.4i 11.2  1.4i
Lipid calories (kcal kg1 day1) 0 0 5.7  3.9 5.7  3.9 4.7  3.5 4.7  3.5
Glucose plasma level (mg dL1) 105  10 133  30g 168  58 98  6h 172  62 101  15h
Insulin plasma levels (mU mL1) 54 (19e159) 73 (24e186) 32 (17e122) 144 (94e2385)h 51 (29e153) 168 (93e2239)h
a All values are mean  SD, except insulin plasma levels which are depicted in median (range).
b LG ¼ low glucose (2.5 mg kg1 min1).
c SG ¼ Standard glucose (5.0 mg kg1 min1).
d SAA ¼ standard amino acid intake (1.5 g kg1 d1).
e HAA ¼ high amino acid intake (3.0 g kg1 d1).
f Resting Energy Expenditure according to Schoﬁeld equations.19
g LG vs. SG, p < .05.
h Base vs. Insulin p < .05.
i SAA vs. HAA, p < .05.
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The adolescents received full parenteral nutrition in two
different amounts of amino acids (Table 2). The caloric intake was
adequate or above requirements according to the Schoﬁeld equa-
tions19 (Table 2), but did not signiﬁcantly differ between protocols.
During baseline the adolescents were hyperglycemic, while during
insulin infusion they were normoglycemic and had signiﬁcantly
higher insulin concentrations (Table 2).4.3. Albumin synthesis rates
All patients were hypoalbuminemic (Table 3).
4.3.1. Study 1
Albumin synthesis rates, NOLD, and the contribution of albumin
synthesized in relation to the whole body protein synthesis were
not affected with different glucose intakes (Fig. 3, Table 3).
4.3.2. Study 2
Neither an increased amino acid intake nor the supra-
physiological insulin concentrations affected albumin synthesisTable 3
Albumin synthesis of 8 infants and 9 adolescents admitted to the PICUa
Study 1
LGb SGc
Albumin concentration (g dL1) 2.6  0.4
FSRf (%.d1) 16.3  3.2 16.0  2.2
ASRg (mg kg1 day1) 243  45 243  47
Non-oxidative leucine disposal (mmol kg1 h1) 122  14 124  20
Contribution to total protein synthesis (%) 6.7  1.9 6.7  1.9
a All values are mean  SD.
b LG ¼ low glucose (2.5 mg kg1 min1).
c SG ¼ Standard glucose (5.0 mg kg1 min1).
d SAA ¼ standard amino acid intake (1.5 g kg1 d1).
e HAA ¼ high amino acid intake (3.0 g kg1 d1).
f FSR ¼ fractional synthesis rate.
g ASR ¼ absolute synthesis rate.
h Base vs. Insulin; p < .05.
i SAA vs. HAA; p < .05.
j SAA vs. HAA, p ¼ .05.rates.NOLDwasnot signiﬁcantlyaffectedby thedifferentaminoacid
intakes, but was lower (p < .05) during insulin infusion in the
adolescents (Table 3). The contribution of albumin synthesized in
relation to the whole body protein synthesis was comparable
between protocols and not affected by either intervention (Fig. 3,
Table 3).
We did not observe an effect of timing or order of protocol
sequence on the outcome measures.5. Discussion
Our study provides insight in albumin synthesis rates in criti-
cally ill children of two different age groups. The data obtained in
our study are consistent with previous observations in critically ill
adults that, although in a hypoalbuminemic condition, albumin
synthesis rates were high during inﬂammation and metabolic
stress. Nutritional interventions with various levels of glucose and
amino acid intake, and insulin infusion did not further stimulate
albumin synthesis rates, nor did they increase the contribution of
albumin to whole body protein synthesized.Study 2
SAAd HAAe
Base Insulin Base Insulin
2.6  0.6 2.5  0.3
23.7  13.8 27.5  19.0 22.6  8.3 23.8  11.0
299  172 330  211 276  99 296  148
153  36 128  38h 173  31j 149  38h i
6.9  4.4 8.4  4.4 5.3  1.7 6.5  2.5
Fig. 3. Albumin synthesis in 8 infants and 9 adolescents receiving various nutritional support and insulin, Panel A Albumin fractional synthesis rate (%.day1), Panel B Albumin
absolute synthesis rate (mg kg1 day1), Panel C Contribution of albumin synthesis as ratio to total whole body protein synthesis per day LG ¼ low glucose intake
(2.5 mg kg1 min1), SG ¼ standard glucose (5.0 mg kg1 min1), SAA ¼ Standard amino acid intake (1.5 g kg1 day1), HAA ¼ High amino acid intake (3.0 g kg1 day1),
Base ¼ during baseline, Insulin ¼ during insulin infusion (80 mU m2 min1).
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higher in neonates (12.5e23%)16,22 and infants (15e20%)30,31 than
healthy adults (6e15%)7e10,14,32,33 (Table 4). However, the pop-
ulations studied in these studies, as well as the experimental
conditions, methods and interventions studied differ markedly
(Table 4) and one should be cautious to compare these historical
data. However, in our study high synthesis rates weremore obvious
in the septic adolescents. The synthesis ratesmeasured inour infants
were consistent with those measured in age-related peers.30,31 The
synthesis rates in the adolescents were even slightly higher than
those in (critically) ill adults (11e18%).7,34e37 These relative high
synthesis rates might be explained by their condition, as an
inﬂammatory and catabolic insult, which usually follows after
trauma, surgery or infection, is a strong stimulant for albumin
synthesis in patients.12 These ﬁndings suggest that the adolescents
were in a higher inﬂammatory and catabolic state, compared to the
infants, explaining their relative high synthesis rates for their age.
The latter is supported with a higher leucine ﬂux in the adolescents
(data not shown), an indicator for amino acid turnover as a derivative
measure of catabolism. Furthermore, the C-reactive protein,
a hepatic acute phase protein, was substantially higher in the septic
adolescents.
In contrast to our hypothesis and data in healthy adults and
neonates9,14,16 increasing both parenteral energy (glucose) as well
as amino acid intake did not affect synthesis rates. Although an
unexpected ﬁnding at ﬁrst, it is nevertheless consistent with pub-
lished data in healthy38 as well as post-surgical37 adults receiving
intravenous nutrients. Albumin synthesis rates are less responsive
to parenteral than enteral nutrients.39,40 Parenteral nutrition
bypasses the splanchnic uptake and amino acids are presented to
the liver through the portal venous circulation in lower concen-
trations.41 Studies in piglets suggest that after enteral feeding,
portal rather than arterial amino acids are preferentially used for
hepatic protein synthesis.41 Therefore, the parenteral route of
nutrient supply in our children might be responsible for the lack of
effect of our nutritional interventions, stressing the need for early
enteral nutrition in critically ill children even more.
The lack of nutritional effect could also have been caused by the
medical or surgical condition our patients were in. In health, the
major regulator of (muscle and hepatic) protein synthesis is
increased amino acid availability, since amino acids themselves
modulate cellular processes leading to protein synthesis via
enhanced translation initiation as well as through promoting
translation elongation.42,43 Under conditions of inﬂammation and
cytokine release, muscle protein synthesis is inhibited and lessresponsive to amino acid supply, while hepatic synthesis of
immune/inﬂammatory proteins is greatly increased.44e46 An
increased supply of amino acids moderately attenuates the inhib-
itory response of inﬂammation on muscle protein synthesis.47 In
contrast, a pathway other than nutrient signaling is responsible for
the increased hepatic protein synthesis during an inﬂammatory
insult.48 Our study now shows that albumin synthesis, already
ampliﬁed in our patients, was also not further affected with
changes in nutrient supply.
Of further interest, administration of insulin, a strong anabolic
hormone, previously reported to stimulate albumin synthesis15,49
did not have any effect. Insulin decreased whole body protein
synthesis, indicated by the NOLD, even when a high amino acid
intake was provided. Lang and coworkers50 reported that insulin
failed to stimulate protein synthesis in an animal model of sepsis
via a defect in insulin signaling to a step in translation initiation.
Inﬂammation induces insulin resistance to protein synthesis, which
might explain why hyperinsulinemia in our septic adolescents did
not increase albumin synthesis rates. Because our study is the ﬁrst
to describe the synthesis rates in critically ill infants and adoles-
cents, it is difﬁcult to characterize our results. It is therefore
possible that the synthesis rates measured in our patients are not
further increased by either intervention because they are already at
their maximum.
There are some limitations to our study which need to be taken
into account, some of them inherent to studying critically ill chil-
dren. As mentioned in the statistical description, statistical
comparison between the two protocols was not justiﬁed due to the
wide variations in between the two groups. Furthermore, absolute
albumin synthesis rates are calculated with albumin plasma levels.
However, as we mentioned in the introduction, hypoalbuminemia
is primarily caused by dilution and redistribution secondary to an
altered vascular permeability. Therefore, we potentially under-
estimated the absolute synthesis rates as our study was not able to
correct for dilution and redistribution. However, the data within
the groups are consistent and justify our conclusions that synthesis
rates were high, and unresponsive to change in parenteral nutrients
as well as hyperinsulinemia. We further acknowledge that we only
performed short term nutritional changes in our study. However, as
has been shown in previous studies, albumin synthesis rates can
react acute and fast to these interventions.12e15 Finally, we
acknowledge that 4 septic adolescents received glucocorticoids as
adjuvant therapy. Glucocorticoids impair protein anabolism, also in
the pediatric population51 and are capable of obstructing the
anabolic effects of insulin.52 However, the catabolic properties are
Table 4
Overview of populations and experimental conditions in historical data describing albumin synthesis rates in comparison with present study.
Age Diagnosis n ¼ Route of nutrition Caloric intake
(kcal kg1 d1)a
Protein intake
(g kg1 d1)a
Albumin plas a
level (g.dL1)
Albumin FSR (%.d1) Albumin ASR
(mg.kg1 d1)
Present study Infants (0.8  0.2 yrs) Post-craniofacial surgery 8 Parenteral 12.5e25.9 0 24.8 (20e31) 15.3  1.7 224  42
Present study Adolescents
(15.0  1.2 yrs)
Sepsis/SIRS 9 Parenteral 17.7e52 1.2/3.2 25.5 (22e38) 25.6  16.2 301  158
Van den
Akker et al.16
Premature infants VLBW 15 Parenteral 31.2 (26.0e32.9) 2.4 26 (25e27) 22.9 (17.6e28.0) 228 (187e289)
Bunt et al.22 Premature infants VLBW 24 Parenteral 25e33 0 25  0.6 13.9  1.5 148  17
Jahoor et al.30 Children (7e17 months) Healthy/HIV infected 4/6 Enteral 168  12/ 101  12 3.4  0.3/ 2.3  0.5 34  2.4/ 26  2.9 16  3.3/17  2.0 309  48/247  15
Morlese et al.31 Children (w1 yr) Recovery from
marasmus/kwashiorkor
14 Enteral 30e50 3 w34e40 15.6  1.2/w17 277  30/368  36
De Feo et al.14 Adults
(18e36 yrs)
Healthy 9 e/Enteral 0/40 0/? e 12  2/23  3 e
Caso et al.8 Adults (21e35/>60 yrs) Healthy 8/8 Enteral 1.5 daily REE 15:30:55%b 38.8  0.7/40  1.0 10.1  0.5/9.2  0.4 182  6/144  7
Thalacker-Mercer
et al.9
Adult (21e43/63e79 yrs) Healthy 18/18 Enteral 1.75 daily REE 0.5e1.0 e 14.7  5.6 e
Ballmer et al.33 Adults
(33.4  6.5 yrs)
Healthy 7 e 0 0 47  4 7.2  1.3 157  39
Mansoor et al.7 Adults Healthy/Head injury 5/6 Enteral/Parenteral 34  2/39  2 1.4  0.1/1.5  0.1 33.7  1.2/25  1.2 7.3  0.4/11.4  1.0 91  5/
133  14
Barle et al.32 Adults Laparoscopic
cholecystectomy
9 e 0 0 39.9  1.7 5.9  1.2 109  21
Essen et al.35 Adults Critically ill 15 Parenteral 20e30 0.6e1.1 27  1 12.8  1.2 184  19
Barle et al.36 Adults Critically ill 11 Parenteral and
Enteral
20e30 0.6e1.3 28.2  6.6 16.3  4.1 233  67
Barle et al.37 Adults Post-surgery 7 Parenteral 17.5 0.6 e 15.2  4.7 e
Values are depicted as mean  SD, or as median (range). FSR ¼ Fractional synthesis rate, ASR ¼ Absolute synthesis rate, REE ¼ Resting Energy Expenditure. w Data fro Morlese et al. were partially adapted from ﬁgures.
a Nutritional data were either copied from the manuscript or, when possible, calculated from the data provided.
b Percentage of energy content of meal derived from protein, fat and carbohydrates respectively.
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suppression of protein synthesis.51 We did not ﬁnd a difference in
synthesis rates or effect of insulin therapy in the 4 adolescents who
received glucocorticoids, although our study was not powered to
discover such an effect.6. Conclusion
Although mildly hypoalbuminemic, albumin synthesis rates
were high in post-surgical infants and in septic adolescents.
Synthesis rates did not respond to short term changes in parenteral
intakes of glucose, amino acids, and insulin. The data from our
study, the ﬁrst in the critically ill pediatric population, conﬁrm
previous observations that the low plasma albumin levels are not
due to decreased synthesis rates. Furthermore, during critical
illness albumin synthesis rates were not inﬂuenced by nutrients or
insulin and might be regulated through pathways other than
nutritional signaling.
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